Literature DB >> 12325153

Purification of a functional gene therapy vector derived from Moloney murine leukaemia virus using membrane filtration and ceramic hydroxyapatite chromatography.

Marcel Kuiper1, Raquel M Sanches, James A Walford, Nigel K H Slater.   

Abstract

The ability of membrane ultra- and diafiltration and two chromatography media, Matrex Cellufine Sulfate (Millipore) and Macro-Prep ceramic hydroxyapatite (Bio-Rad), to adsorb, elute, and purify gene therapy vectors based on Moloney murine leukaemia virus (MoMuLV) carrying the 4070A amphotropic envelope protein was studied. Membrane ultra- and diafiltration provided virus concentration up to 160-fold with an average recovery of infectious viruses of 77 +/- 14%. In batch experiments, Macro-Prep ceramic hydroxyapatite (type 2, particle size 40 microm) proved superior to Matrex Cellufine Sulfate for MoMuLV vector particle adsorption. Furthermore, functional vector particles could be eluted using phosphate buffer pH 6.8 (highest titres from >or=300 mM phosphate) from the Macro-Prep adsorbent, with higher specific titres (cfu/mg protein) than the starting material. Similar results were obtained when this ceramic hydroxyapatite was packed into a column and used in a liquid chromatography system. Recovery of transduction-competent virus was between 18 and 31% for column experiments and 32 and 46% for batch experiments. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12325153     DOI: 10.1002/bit.10388

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  9 in total

1.  Selection of novel vesicular stomatitis virus glycoprotein variants from a peptide insertion library for enhanced purification of retroviral and lentiviral vectors.

Authors:  Julie H Yu; David V Schaffer
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 2.  Calcium Orthophosphate-Based Bioceramics.

Authors:  Sergey V Dorozhkin
Journal:  Materials (Basel)       Date:  2013-09-06       Impact factor: 3.623

3.  Tagging retrovirus vectors with a metal binding peptide and one-step purification by immobilized metal affinity chromatography.

Authors:  Kaiming Ye; Sha Jin; Mohammad M Ataai; Jerome S Schultz; Jeanette Ibeh
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

4.  Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification.

Authors:  Canping Jiang; James B Wechuck; William F Goins; David M Krisky; Darren Wolfe; Mohammad M Ataai; Joseph C Glorioso
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

5.  Optimised concentration and purification of retroviruses using membrane chromatography.

Authors:  D J McNally; D Darling; F Farzaneh; P R Levison; N K H Slater
Journal:  J Chromatogr A       Date:  2014-03-15       Impact factor: 4.759

6.  Sequential two-step chromatographic purification of infectious poliovirus using ceramic fluoroapatite and ceramic hydroxyapatite columns.

Authors:  Yae Kurosawa; Shigehiro Sato; Tsuneo Okuyama; Masato Taoka
Journal:  PLoS One       Date:  2019-09-19       Impact factor: 3.240

Review 7.  Downstream processing of cell culture-derived virus particles.

Authors:  Michael W Wolf; Udo Reichl
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

8.  Marine-Derived Biowaste Conversion into Bioceramic Membrane Materials: Contrasting of Hydroxyapatite Synthesis Methods.

Authors:  Yusuf Wibisono; Alien Yala Pratiwi; Christine Ayu Octaviani; Cut Rifda Fadilla; Alfian Noviyanto; Epi Taufik; Muhammad K H Uddin; Fajri Anugroho; Nurul Taufiqu Rochman
Journal:  Molecules       Date:  2021-10-20       Impact factor: 4.411

9.  Scanning electron microscopy-based approach to understand the mechanism underlying the adhesion of dengue viruses on ceramic hydroxyapatite columns.

Authors:  Maiko Saito; Yae Kurosawa; Tsuneo Okuyama
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.